▶ 調査レポート

世界の血管造影検査室市場2023年-2028年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Angio Suites Market- Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の血管造影検査室市場2023年-2028年:成長・動向・新型コロナの影響・市場予測 / Angio Suites Market- Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028) / MRC2303G116資料のイメージです。• レポートコード:MRC2303G116
• 出版社/出版日:Mordor Intelligence / 2023年2月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥712,500 (USD4,750)▷ お問い合わせ
  Corporate License¥1,312,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の市場調査書によると、世界の血管造影検査室市場規模が、予測期間中(2022年-2027年)CAGR 8.9%で増加すると推測されています。本書では、血管造影検査室の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(バイプレーン型、シングルプレーン型)分析、用途別(血管形成術、治療ステント術、血管造影、障害物バイパス、その他)分析、地域別(アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン)分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Siemens Healthcare GmbH、Canon Medical Systems Corporation、GE Healthcare、Koninklijke Philips N.V.、Carestream Healthなどが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の血管造影検査室市場規模:種類別
- バイプレーン型血管造影検査室の市場規模
- シングルプレーン型血管造影検査室の市場規模
・世界の血管造影検査室市場規模:用途別
- 血管形成術における市場規模
- 治療ステント術における市場規模
- 血管造影における市場規模
- 障害物バイパスにおける市場規模
- その他用途における市場規模
・世界の血管造影検査室市場規模:地域別
- 北米の血管造影検査室市場規模
アメリカの血管造影検査室市場規模
カナダの血管造影検査室市場規模
メキシコの血管造影検査室市場規模

- ヨーロッパの血管造影検査室市場規模
ドイツの血管造影検査室市場規模
イギリスの血管造影検査室市場規模
フランスの血管造影検査室市場規模

- アジア太平洋の血管造影検査室市場規模
中国の血管造影検査室市場規模
日本の血管造影検査室市場規模
インドの血管造影検査室市場規模

- 南米/中東の血管造影検査室市場規模
ブラジルの血管造影検査室市場規模
アルゼンチンの血管造影検査室市場規模
サウジアラビアの血管造影検査室市場規模
・競争状況
・市場機会・将来動向

The angio suites market is expected to register a CAGR of 8.9% over the forecast period (2022-2027).

While the sudden outbreak of the COVID-19 pandemic has impacted most of the business sectors negatively, the angio suites market has shown significant growth in 2020 and 2021 owing to the increase in cases of heart disease and other chronic diseases during the pandemic. The demand for angio suites increased because these are the advanced interventions used for the accurate and efficient diagnosis, which help to visualize the inside of human blood vessels, particularly the arteries. The uncontrolled and sudden increase in covid-19 cases resulted in an increased patient population suffering from heart disease and this increased demand for advanced angio suites.

An article published in April 2020 titled “How to Handle a COVID-19 Patient in the Angiographic Suite” mentioned that to avoid contamination, isolated patients were treated in separate angio suites, which were equipped with ventilation systems like an operating room. But procedures for life-threatening conditions (e.g., thrombectomy for stroke, acute mesenteric ischemia, endovascular aortic aneurysm repair for aortic ruptures), non-deferrable oncologic treatments (e.g., interventional procedures bridge to liver transplant, selected percutaneous ablations), and organ-saving procedures (e.g., urgent diabetic foot angioplasty) were performed in most of the hospitals whenever deemed to be necessary during the pandemic. Hence, Covid-19 had a significant impact on the growth of the studied market.

Factors such as the increasing burden of the geriatric population coupled with cardiovascular diseases, the growing need for minimally invasive surgeries, the high of artificial intelligence (AI) and analytics in diagnostic imaging, and rapid technological advancements in diagnostic imaging are among the major factors expected to intensify the growth of the angio suites market. For instance, the World Health Organization (WHO) data published in October 2021 estimated that between 2015 and 2050, the proportion of the world’s older population of age 60 years or more would nearly double from 12% to 22%. And 80% of older people are anticipated to be living in low- and middle-income countries in the year 2050. This population is more prone to getting cardiovascular diseases and other chronic illnesses. This is expected to demand more advanced diagnostic procedures, and it is anticipated to drive the growth of the angio suites used for diagnostic imaging driving the studied market growth over the forecast period.

In addition, awareness among the target population for early diagnosis and an expanded scope of clinical applications are also likely to enhance the growth of the studied market. Furthermore, the rise in the investments, funds, and grants by public-private organizations is anticipated to contribute to the growth of the market studied over the forecast period. Therefore, as per the aforesaid factors, the global angio suites market is poised to witness growth over the forecast period.

Angio Suites Market Trends

Angioplasty by Application Segment is Expected to Witness Growth Over the Forecast Period

Angioplasty is a procedure that is used to open blocked coronary arteries caused by coronary artery disease—owing to the rising prevalence of cardiovascular diseases. The angioplasty segment is anticipated to witness projected growth over the forecast period.

The burden of heart and circulatory disease worldwide has been more prevalent recently. According to the British Heart Foundation, heart and circulatory diseases cause one-third of all deaths in the United Kingdom (UK). As per the data reported by the American College of Cardiology in 2020, approximately 1.2 million angioplasties are performed in a year in the United States. Moreover, According to the Centers for Disease and Prevention (CDC) in 2022, about 659,000 people in the United States die from heart disease each year which was 1 in every 4 deaths. As the burden of coronary heart disease is increasing the demand for angioplasty is also accelerating. As coronary angioplasty is used to widen blocked or narrowed coronary arteries, allowing the patient to be safe, the demand for angioplasty is booming currently. This is anticipated to drive the growth of the studied market in the near future.

Moreover, angioplasty is less scarring, provides reduced side effects from the surgery, higher success rate, minimal invasion, and speedy recovery contribute as major advantages which are among the factors, angioplasty is popular among patients and healthcare professionals. Therefore, owing to the factors mentioned above, the angioplasty segment is anticipated to witness growth over the forecast period.

North America is Expected to Dominate the Market over the Forecast Period

North America is expected to be a dominant region in the angio suites market owing to the increasing number of investments, technological advancements, and the increased burden of cardiovascular and other chronic diseases.

Cardiovascular diseases (CVDs) are the leading cause of death across the globe, among other life-threatening diseases. The global burden of cardiovascular disease is estimated to be around 29% of the total deaths in the future. According to the American Heart Association, by 2030, 40.5% of the United States population is expected to suffer from cardiovascular disease. This increasing burden of CVDs is anticipated to drive the growth of the studied market in the region.

Adding to that, as per a press release in July 2021, the governments of Canada and Quebec announced their plans to invest in 209 infrastructure projects to modernize, redevelop, and upgrade health and social services institutions in Quebec, including hospitals, residential and long-term care centers, local community service centers, and rehabilitation centers. The federal Minister of Infrastructure and Communities, and Minister of Health and Social Services, announced a total of USD 188,3 million in funding for these 209 infrastructure projects. As a result, for the development and implementation of advanced medical devices, the angio suites are also anticipated to create demand for infrastructure development. Hence, it is anticipated to drive the growth of the studied market in the countries. Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in the North America Region.

Angio Suites Market Competitor Analysis

The Angio suites market is fragmented in nature due to the presence of a number of companies globally. The studied market consists of several international as well as local companies which hold the majority of the market shares and are well known, including Siemens Healthcare GmbH, Canon Medical Systems Corporation, GE Healthcare, and Koninklijke Philips N.V., Carestream Health, and Shimadzu Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Geriatric Population Coupled with Cardiovascular Diseases
4.2.2 Growing Need for Minimally Invassive Surgeries
4.2.3 High of Artificial Intelligence (AI) and Analytics in Diagnostic Imaging
4.2.4 Rapid Technological Advancements in Diagnostic Imaging
4.3 Market Restraints
4.3.1 High Risk of Radiation Exposure
4.3.2 High Cost Associated with Installation
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Biplane Angio Suites
5.1.2 Single Plane Angio Suites
5.2 By Application
5.2.1 Angioplasty
5.2.2 Therapeutic Stenting
5.2.3 Angiograms
5.2.4 Obstruction Bypass
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Siemens Healthcare GmbH
6.1.2 Canon Medical Systems Corporation
6.1.3 GE Healthcare
6.1.4 Koninklijke Philips N.V.
6.1.5 Carestream Health
6.1.6 Shimadzu Corporation
6.1.7 FUJIFILM Corporation
6.1.8 ESAOTE SPA
6.1.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.1.10 Hologic, Inc.
6.1.11 PLANMED OY
6.1.12 IMRIS
6.1.13 3D Systems, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS